(Total Views: 532)
Posted On: 04/20/2021 11:30:26 AM
Post# of 149265
Leronlimab still being call "investigational" in the Philippines.
This is what PR is for, to change the perception of being "experimental" into being the SOC. This is not about the science or the numbers, this is about changing the perception through PR to make the story that Leronlimab is the go to drug.
The press we got in the Philippines needs to lead to a feature story in Brazil and stories in Canada. A good PR firm could easily spin this into a major feature in the USA eventually. We have stories dating back to March 2020
This is what PR is for, to change the perception of being "experimental" into being the SOC. This is not about the science or the numbers, this is about changing the perception through PR to make the story that Leronlimab is the go to drug.
The press we got in the Philippines needs to lead to a feature story in Brazil and stories in Canada. A good PR firm could easily spin this into a major feature in the USA eventually. We have stories dating back to March 2020
(3)
(0)Scroll down for more posts ▼
